skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Re your comment to Murray on tax loss selling bargains. Seems like PLI made a significant move following FDA approval of one of its research streams yesterday. IT and AVO have made significant moves off their respective lows recently on no news that I see. Could this be the end of their tax loss selling season, isn't it a bit early? When would you normally look for these 'bargains'? Is this a reasonable strategy to pursue?
Thanks again Peter
Read Answer Asked by Peter on October 29, 2015
Q: Please comment on their results. What were the estimate and did they miss or beat them. Thanks
Read Answer Asked by Imtiaz on October 29, 2015
Q: Your comments on their 3rd quarter results please. Looks like they continue to forge ahead. I have most of the balanced portfolio with full positions, and half of the growth at 3% positions or less for a total of 60% per your suggestion. Re your philosophy of adding to a winning position, and considering Kinaxis performance to date would you bring it up to a full position.
Thanks Peter
Read Answer Asked by Peter on October 29, 2015
Q: I am considering stepping into a small position in Tata Motors - do you have any negative (or positive) thoughts on it?
Thanks so much. Your opinion is much appreciated!
Susan
Read Answer Asked by Susan on October 29, 2015
Q: Can you please explain what the difference is between the Mawer Balanced (104) and the Mawer Balanced Tax Effective (105) and if one would be more suited to a registered vs non registered account. Thank you.
Read Answer Asked by Alan on October 29, 2015
Q: Not really a question, more a reminisce and comment on the shorts.I recall years ago a short attack on Fairfax Financial, I think it came shortly after they listed in the U.S. The stock was driven down into the $70 dollar range. The innuendo was that Fairfax management was using off-shore companies in a less than kosher way. I just looked at my FFH this morning and it is at $650, high earlier this year $739.
Best defense against shorts (the mudslinging variety) is to know the company and have faith in your investment analysis and the management (and of course one particularly un-conflicted investment web site).
Many thanks to the 5i staff.
Mike
Read Answer Asked by michael on October 29, 2015
Q: Hello 5i, Can I please get your views on this shipping company. I came across this company when researching oil shipping companies and then noticed Zaks research had a few upgrades, then the ceo was on BNN today. Their fleet of ships is increasing, their eps seems to be growing as is their dividend. I cannot decipher their book value or their debt levels. thanks
Read Answer Asked by pietro on October 29, 2015
Q: Is PPY a great long term buy at these level ? Any specific reason why it has been so weak lately ? Thank you.
Read Answer Asked by Pierre on October 29, 2015
Q: What is your current opinion on the growth and utilization of this stock given its published figures?
Read Answer Asked by ANDREW on October 29, 2015
Q: Peter, my two real estate companies in my portfolio are CIG and FSV and I want to rebalance down to 10 or 12%. I have read your recent comments about these companies and would like your opinion as to what two or three real estate companies you would use in a balanced portfolio. I am thinking of selling both and buying some stocks with more upside.

Thanks, Stephen
Read Answer Asked by stephen on October 29, 2015
Q: Hi team, I recently sold MCD (in an RRSP) after the run up, and am looking to redeploy cash into a blue chip healthcare or pharma stock in the US. I'm looking for reliable dividends with capital appreciation, and planning to hold for three plus years. MRK and PFE are looking like good candidates, do you have any favourite blue chip healthcare stocks that you think would be a better fit?
Thanks, Alex
Read Answer Asked by Alexander on October 29, 2015
Q: Until recently I had no healthcare exposure. My plan is to add about 4 positions in the US large cap healthcare/bio space. So far I have purchased JNJ and GILD. Can you suggest 2 or 3 other names? Based on the research reports I have read I am leaning toward CELG and AGN, but I'd appreciate your opinion. Thank-you.
Read Answer Asked by Albert on October 29, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!